We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USAP
76
DELISTED
Universal Stainless & Alloy
USAP
$1.78M 0.03%
+65,060
New +$1.92M
ZTS icon
77
Zoetis
ZTS
$32.1B
$1.75M 0.03%
10,078
+5,889
+141% +$980K
INOD icon
78
Innodata
INOD
$1.99B
$1.66M 0.03%
111,814
+84,509
+310% +$878K
CVGW
79
DELISTED
Calavo Growers
CVGW
$1.6M 0.03%
70,514
+59,940
+567% +$1.57M
HUMA icon
80
Humacyte
HUMA
$179M
$1.55M 0.03%
+322,851
New +$1.68M
TOI icon
81
The Oncology Institute
TOI
$535M
$1.55M 0.03%
3,360,052
– –
HXL icon
82
Hexcel
HXL
$7.83B
$1.49M 0.02%
23,879
+18,620
+354% +$1.25M
CMAX
83
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.48M 0.02%
530,232
+1,124
+0.2% +$3.51K
RMD icon
84
ResMed
RMD
$28.9B
$1.45M 0.02%
+7,576
New +$1.54M
COO icon
85
Cooper Companies
COO
$14B
$1.45M 0.02%
16,609
+11,466
+223% +$1.07M
MATW icon
86
Matthews International
MATW
$857M
$1.45M 0.02%
57,723
+45,285
+364% +$1.24M
INTU icon
87
Intuit
INTU
$79.6B
$1.44M 0.02%
+2,197
New +$1.36M
CSV icon
88
Carriage Services
CSV
$598M
$1.44M 0.02%
53,584
+35,605
+198% +$934K
TDY icon
89
Teledyne Technologies
TDY
$29.4B
$1.42M 0.02%
3,656
+2,680
+275% +$1.06M
OMIC
90
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.4M 0.02%
166,162
– –
TMDX icon
91
Transmedics
TMDX
$2.56B
$1.4M 0.02%
+9,298
New +$1.12M
USNA icon
92
Usana Health Sciences
USNA
$403M
$1.35M 0.02%
29,742
+22,251
+297% +$1.02M
CRMT icon
93
America's Car Mart
CRMT
$31.4M
$1.34M 0.02%
22,267
+18,290
+460% +$1.1M
MAN icon
94
ManpowerGroup
MAN
$2.43B
$1.33M 0.02%
19,104
+11,373
+147% +$842K
VYX icon
95
NCR Voyix
VYX
$1.13B
$1.33M 0.02%
+107,398
New +$1.35M
BCSF icon
96
Bain Capital Specialty
BCSF
$823M
$1.3M 0.02%
79,569
+54,213
+214% +$883K
NVDA icon
97
NVIDIA
NVDA
$4.91T
$1.28M 0.02%
10,400
+910
+10% +$92K
ZBRA icon
98
Zebra Technologies
ZBRA
$12.7B
$1.28M 0.02%
+4,147
New +$1.26M
RVTY icon
99
Revvity
RVTY
$12.3B
$1.26M 0.02%
12,058
+8,045
+200% +$854K
CDMO
100
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.26M 0.02%
176,586
+74,797
+73% +$572K
2 3
4
5 6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.